Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Nucl Med Biol. 2014 Aug 13;42(1):19–27. doi: 10.1016/j.nucmedbio.2014.08.007

Fig. 4.

Fig. 4

Tumor-to-normal tissue ratios in athymic mice bearing BT474M1 xenografts for trastuzumab labeled with NHS-[131I]IB-d-EEEG (filled circles) and Mal-d-GEEEK-[125I]IB (open circles): liver (A), lungs (B), spleen (C), blood (D), kidneys (E), muscle (F). *No significant difference between the two tracers (P > 0.05).